Alexandria Venture Investments Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 7
- Investments
- 304
- Portfolio
- 143
- Exits
- 93
Alexandria Venture Investments General Information
Description
Founded in 1996, Alexandria Venture Investments is a venture capital firm based in Pasadena, California. The firm prefers to invest in seed-stage, early-stage, and growth-stage companies. The firm also seeks to invest in healthcare, information technology, materials, and resources sectors.
Contact Information
Year Founded
1996
Investor Status
Actively Seeking New Investments
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
- 26 North Euclid Avenue
- Pasadena, CA 91101
- United States
+1 (626) 000-0000
Alexandria Venture Investments Investments (304)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Creyon Bio | 08-Mar-2022 | Early Stage VC | 0000 | Drug Discovery | Pre-Clinical Trials | |
| 00000000 | 15-Feb-2022 | 00000 00000 | 00000 | Drug Discovery | Generating Revenue | |
| 000000 00000000000 | 15-Feb-2022 | 00000 00000 | 0000 | Discovery Tools (Healthcare) | Generating Revenue | |
| 000000 00000000000 | 09-Feb-2022 | 00000 00000 | 00000 | Drug Discovery | Generating Revenue | |
| 00000 000 | 05-Jan-2022 | 00000 00000 | 00000 | Drug Discovery | Generating Revenue | |
| 00000 000000000 | 21-Dec-2021 | 00000 00000 | 0000 | Drug Discovery | Product Development | |
| 000000000 | 14-Dec-2021 | 00000 00000 | 000.00 | Other Agriculture | Generating Revenue/Not Profitable | |
| 00000000 | 09-Dec-2021 | 0000 00000 | 00.00 | Drug Discovery | Startup | |
| Fountain Therapeutics | 18-Nov-2021 | Early Stage VC | 0000 | Drug Discovery | Generating Revenue | |
| DEKA Biosciences | 16-Nov-2021 | Early Stage VC | 0000 | Biotechnology | Generating Revenue |
Alexandria Venture Investments Exits (93)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| GreenLight Biosciences | 04-Feb-2022 | Reverse Merger | 00000 |
| 00000 00000 | 07-Jan-2022 | 000 | 0000 |
| 0000 | 17-Dec-2021 | 0000000 000000 | 00.00 |
| 0000000 0000000000 | 04-Nov-2021 | 000 | 00000 |
| 0000 00000000000 | 02-Nov-2021 | 000 | 000.00 |
| 0000000000 0000000 | 07-Oct-2021 | 000000000000000000 | |
| 000000 0000 | 30-Sep-2021 | 0000000 000000 | 00000 |
| 000000 00000000000 | 24-Sep-2021 | 000000000000000000 | 00000 |
| DiCE Molecules | 15-Sep-2021 | IPO | 00000 |
| eFFECTOR Therapeutics | 26-Aug-2021 | Reverse Merger | 00000 |
Alexandria Venture Investments Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialAlexandria Venture Investments Team (9)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Jenna Foger | Senior Vice President, Science & Technology | 0 | 0 | Pasadena, CA | |
| Monica Beam Ph.D | Senior Vice President, Science & Technology | 0 | 0 | Pasadena, CA | |
| Aaron Jacobson | Senior Vice President, Venture Counsel | Pasadena, CA | |||
| Jeff Stevens | Vice President, Science & Technology | 0 | 0 | Pasadena, CA | |
| Dean Shigenaga | President & Chief Financial Officer, Alexandria Real Estate Equities | Pasadena, CA |
Alexandria Venture Investments Co-Investors (619)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| ARCH Venture Partners | 23 | 0 | 0 |
|
|
| Casdin Capital | 00 | 0 | 0 |
|
|
| GV | 00 | 0 | 0 |
|
|
| RA Capital Management | 00 | 0 | 0 |
|
|
| Pfizer Ventures | 00 | 0 | 00 |
|
|